Skip to main content
Clinical Trials/ACTRN12619001093178
ACTRN12619001093178
Recruiting
未知

Exercise rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy: Impact and mechanisms

niversity of New South Wales0 sites64 target enrollmentAugust 8, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of New South Wales
Enrollment
64
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 8, 2019
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Grade 2 or 3 chemotherapy\-induced peripheral neuropathy (symptoms affecting function)
  • 2\.At least 3 months post\-neurotoxic cancer treatment and not planned for neurotoxic cancer treatment in the next 8 weeks
  • 3\.Previously treated with cancer treatments for which neuropathy is a known side effect
  • 4\.Greater than 18 years of age
  • 5\.Able to provide written informed consent
  • 6\.Cleared by a physician to participate in a structured exercise program

Exclusion Criteria

  • 1\.Eastern Cooperative Oncology Group (ECOG) performance status equal to or greater than 3
  • 2\.Patients with known peripheral neuropathy prior to neurotoxic cancer treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials